Law360, New York (November 03, 2009) -- Twin patent lawsuits brought by Hoffmann-La Roche Inc. accusing generic-drug maker Teva Pharmaceuticals USA Inc. and its Gate Pharmaceuticals division of infringing patents related to a popular osteoporosis drug have been dismissed because Teva dropped an application to make generic Boniva.
Judge Stanley R. Chesler's order, entered Monday in the U.S. District Court for the District of New Jersey, put the final stamp on the without-prejudice dismissals. Court papers noted the...
